152 related articles for article (PubMed ID: 16690170)
1. A phosphonamidate containing aromatic N-terminal amino group as inhibitor of leucine aminopeptidase-design, synthesis and stability.
Mucha A; Kunert A; Grembecka J; Pawełczak M; Kafarski P
Eur J Med Chem; 2006 Jun; 41(6):768-72. PubMed ID: 16690170
[TBL] [Abstract][Full Text] [Related]
2. The most potent organophosphorus inhibitors of leucine aminopeptidase. Structure-based design, chemistry, and activity.
Grembecka J; Mucha A; Cierpicki T; Kafarski P
J Med Chem; 2003 Jun; 46(13):2641-55. PubMed ID: 12801228
[TBL] [Abstract][Full Text] [Related]
3. [Affinity labeling of leucine aminopeptidase with new substrate analog inhibitors].
Fittkau S; Schunck WH; Mootsi S
Acta Biol Med Ger; 1976; 35(3-4):365-78. PubMed ID: 970045
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and structure activity relationships of novel non-peptidic metallo-aminopeptidase inhibitors.
Albrecht S; Defoin A; Salomon E; Tarnus C; Wetterholm A; Haeggström JZ
Bioorg Med Chem; 2006 Nov; 14(21):7241-57. PubMed ID: 16844380
[TBL] [Abstract][Full Text] [Related]
5. Unusual activity pattern of leucine aminopeptidase inhibitors based on phosphorus containing derivatives of methionine and norleucine.
Pícha J; Liboska R; Buděšínský M; Jiráček J; Pawełczak M; Mucha A
J Enzyme Inhib Med Chem; 2011 Apr; 26(2):155-61. PubMed ID: 20578976
[TBL] [Abstract][Full Text] [Related]
6. Potent new leucine aminopeptidase inhibitor of novel structure synthesised by a modified Wadsworth-Emmons (Horner) Wittig procedure.
Walker B; Darkins PA; McKervey MA; Moncrieff HM; Lynas JF
Bioorg Med Chem Lett; 2000 Jul; 10(13):1481-2. PubMed ID: 10888337
[TBL] [Abstract][Full Text] [Related]
7. Identification of cytosolic leucyl aminopeptidase (EC 3.4.11.1) as the major cysteinylglycine-hydrolysing activity in rat liver.
Jösch C; Klotz LO; Sies H
Biol Chem; 2003 Feb; 384(2):213-8. PubMed ID: 12675513
[TBL] [Abstract][Full Text] [Related]
8. A synthetic method for diversification of the P1' substituent in phosphinic dipeptides as a tool for exploration of the specificity of the S1' binding pockets of leucine aminopeptidases.
Vassiliou S; Xeilari M; Yiotakis A; Grembecka J; Pawełczak M; Kafarski P; Mucha A
Bioorg Med Chem; 2007 May; 15(9):3187-200. PubMed ID: 17337192
[TBL] [Abstract][Full Text] [Related]
9. Binding structure of the leucine aminopeptidase inhibitor microginin FR1.
Kraft M; Schleberger C; Weckesser J; Schulz GE
FEBS Lett; 2006 Dec; 580(30):6943-7. PubMed ID: 17157838
[TBL] [Abstract][Full Text] [Related]
10. Biochemical characterization and structural prediction of a novel cytosolic leucyl aminopeptidase of the M17 family from Schizosaccharomyces pombe.
Herrera-Camacho I; Rosas-Murrieta NH; Rojo-Domínguez A; Millán L; Reyes-Leyva J; Santos-López G; Suárez-Rendueles P
FEBS J; 2007 Dec; 274(23):6228-40. PubMed ID: 18028193
[TBL] [Abstract][Full Text] [Related]
11. Computer-aided design and activity prediction of leucine aminopeptidase inhibitors.
Grembecka J; Sokalski WA; Kafarski P
J Comput Aided Mol Des; 2000 Aug; 14(6):531-44. PubMed ID: 10921770
[TBL] [Abstract][Full Text] [Related]
12. Novel fluoropeptidomimetics: synthesis, stability studies and protease inhibition.
Annedi SC; Majumder K; Wei L; Oyiliagu CE; Samson S; Kotra LP
Bioorg Med Chem; 2005 Apr; 13(8):2943-58. PubMed ID: 15781404
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and activity evaluation of a new bestatin derivative LYP2 as an aminopeptidase N inhibitor.
Luan Y; Wang Q; Liu N; Mou J; Jiao X; Fang H; Li M; Xu W
Anticancer Drugs; 2011 Jan; 22(1):99-103. PubMed ID: 21048494
[TBL] [Abstract][Full Text] [Related]
14. Novel cyclic-imide peptidomimetics as aminopeptidase N inhibitors. Structure-based design, chemistry and activity evaluation. II.
Li Q; Fang H; Wang X; Xu W
Eur J Med Chem; 2010 Apr; 45(4):1618-26. PubMed ID: 20129718
[TBL] [Abstract][Full Text] [Related]
15. Amino-benzosuberone: a novel warhead for selective inhibition of human aminopeptidase-N/CD13.
Albrecht S; Al-Lakkis-Wehbe M; Orsini A; Defoin A; Pale P; Salomon E; Tarnus C; Weibel JM
Bioorg Med Chem; 2011 Feb; 19(4):1434-49. PubMed ID: 21292493
[TBL] [Abstract][Full Text] [Related]
16. Individual stereoisomers of phosphinic dipeptide inhibitor of leucine aminopeptidase.
Mucha A; Lämmerhofer M; Lindner W; Pawełczak M; Kafarski P
Bioorg Med Chem Lett; 2008 Mar; 18(5):1550-4. PubMed ID: 18262419
[TBL] [Abstract][Full Text] [Related]
17. Potent macrocyclic inhibitors of insulin-regulated aminopeptidase (IRAP) by olefin ring-closing metathesis.
Andersson H; Demaegdt H; Johnsson A; Vauquelin G; Lindeberg G; Hallberg M; Erdelyi M; Karlen A; Hallberg A
J Med Chem; 2011 Jun; 54(11):3779-92. PubMed ID: 21476495
[TBL] [Abstract][Full Text] [Related]
18. Engineering d-amino acid containing novel protease inhibitors using catalytic site architecture.
Annedi SC; Biabani F; Poduch E; Mannargudi BM; Majumder K; Wei L; Khayat R; Tong L; Kotra LP
Bioorg Med Chem; 2006 Jan; 14(1):214-36. PubMed ID: 16198572
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and preliminary studies of the activity of novel derivatives of N-cinnamoyl-L-aspartic acid as inhibitors of aminopeptidase N/CD13.
Liu Y; Shang L; Fang H; Zhu H; Mu J; Wang Q; Wang X; Yuan Y; Xu W
Bioorg Med Chem; 2009 Oct; 17(20):7398-404. PubMed ID: 19782572
[TBL] [Abstract][Full Text] [Related]
20. Structure-guided, single-point modifications in the phosphinic dipeptide structure yield highly potent and selective inhibitors of neutral aminopeptidases.
Vassiliou S; Węglarz-Tomczak E; Berlicki Ł; Pawełczak M; Nocek B; Mulligan R; Joachimiak A; Mucha A
J Med Chem; 2014 Oct; 57(19):8140-51. PubMed ID: 25192493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
